Concepedia

Frederik C. Grønvald

FC

Statistics

Publications

5

Citations

421

H-Index

5

Active since

1985

Affiliations

Novo Holdings (Denmark)(Current)

Novo Nordisk (Denmark)

Frederik C. Grønvald is an author at Novo Holdings (Denmark) specializing in neuropharmacology, pharmacology, and psychopharmacology.

Publications per year

1985–1993

5

Publications

5

A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum

Peter H. Andersen, Frederik C. Grønvald, Jens Aas Jansen · Life Sciences · 1985 · 143 citations · Full text

, , +16

Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivo

Peter H. Andersen, Erik B. Nielsen, Frederik C. Grønvald · European Journal of Pharmacology · 1986 · 98 citations

, , +6

NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists

Peter H. Andersen, Frederik C. Grønvald, Rolf Hohlweg et al. · European Journal of Pharmacology · 1992 · 91 citations · Full text

, , +10

Specific binding of 3H-SCH 23390 to dopamine D1 receptors

Peter H. Andersen, Frederik C. Grønvald · Life Sciences · 1986 · 55 citations

, , +14

[11C]NNC 687 and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey

Christer Halldin, Christian Foged, Lars Farde et al. · Nuclear Medicine and Biology · 1993 · 34 citations

, , +14

1–5 of 5